Dan Nathan's SPDR S&P Biotech ETF Trade


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Dan Nathan shared with the audience of CNBC's Options Action his bullish trading idea in SPDR S&P Biotech (ETF) (NYSE: XBI).


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

He thinks that bad news is already priced in and he explained that the real fear about the biotech space is that the Democrats will win the Presidency, the Senate and the Congress, which would make serious headwinds for drug pricing. He doesn't believe that the Democrats are going to win everything and he sees a chance for a potential recovery for the biotech stocks by the end of the year

Nathan thinks the best way to set up a long position is with the January 60/75 bullish call spread, which costs $4. The trade breaks even at $64 or 7.15 percent higher and it can maximally make $11 if the stock jumps to $75 or higher.

Posted In: BiotechCNBCOptionsMarketsMediaGeneralDan NathanOptions Action